Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology

1 · Sector

Weight and 12M allocation change

Financials99.9%+83.96 ppMaterials0.0%-2.85 ppEnergy0.0%-3.56 ppUtilities0.0%-3.91 ppReal Estate0.0%-3.96 ppCommunication Services0.0%-5.38 ppConsumer Discretionary0.0%-7.20 ppConsumer Staples0.0%-9.27 ppIndustrials0.0%-13.40 ppHealth Care0.0%-16.54 ppInformation Technology0.0%-17.88 pp

2 · Industry

Inside Health Care

Pharmaceuticals0.01%-5.35 ppHealth Care Equipment0.00%-3.54 ppBiotechnology0.00%-2.36 ppManaged Health Care0.00%-1.88 ppLife Sciences Tools & Services0.00%-1.78 ppHealth Care Services0.00%-0.95 ppHealth Care Distributors0.00%-0.35 ppHealth Care Facilities0.00%-0.22 ppHealth Care Supplies0.00%-0.10 ppHealth Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Biotechnology

Biotechnology0.00%-2.360 pp
Broad

The loss is shared across much of the industry.

View all contributions →
Biotechnology · weight
0.00%
Industry change · 12M
-2.36 pp
Biotechnology · contribution
-2.360 pp
Company participation
0%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Aug 2020 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
Amgen →
AMGN
United States$148.4bn0.001%-0.000 pp-0.680 pp+24.8%No
AbbVie →
ABBV
United States$169.0bn0.001%+0.000 pp-0.528 pp+53.9%No
Gilead Sciences →
GILD
United States$83.7bn0.000%-0.000 pp-0.437 pp+9.0%No
Vertex Pharmaceuticals →
VRTX
United States$72.7bn0.000%-0.000 pp-0.251 pp+55.0%No
Biogen →
BIIB
United States$45.5bn0.000%-0.000 pp-0.220 pp+30.9%No
Regeneron Pharmaceuticals →
REGN
United States$58.2bn0.000%-0.000 pp-0.148 pp+113.7%No
Incyte →
INCY
United States$21.1bn0.000%-0.000 pp-0.096 pp+17.8%No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.